10-Q: Edgewell Q3 Earnings Decline Amid Sales Slump

Edgewell Personal Care Company reported a significant decline in third-quarter net earnings and sales, driven by volume decreases and increased promotional activity in North America.

Summary

• Net sales for the third quarter of fiscal 2025 decreased 3.2% to $627.2 million, with organic net sales down 4.2%.
• Net earnings for the third quarter of fiscal 2025 were $29.1 million, a significant drop from $49.0 million in the prior year quarter.
• Diluted EPS for the third quarter of fiscal 2025 was $0.62, down from $0.98 in the prior year.
• For the first nine months of fiscal 2025, net sales decreased 2.9% to $1,686.3 million, and net earnings were $56.0 million, down from $89.8 million.
• Gross profit for the third quarter of fiscal 2025 decreased 6.5% to $268.5 million, with gross margin declining 150 basis points to 42.8%.
• Restructuring charges significantly increased to $16.0 million in the third quarter of fiscal 2025 and $32.4 million for the nine months, up from $3.1 million and $13.1 million respectively in the prior year.
• Cash flow provided by operating activities for the first nine months of fiscal 2025 was $44.3 million, a substantial decrease from $157.3 million in the prior year period.
• The Feminine Care reporting unit's fair value exceeded its carrying value by less than 10% as of June 30, 2025, following an interim impairment analysis triggered by its financial performance.

Sentiment

Score: 3

Explanation: The company reported significant declines across key financial metrics including net sales, net earnings, and EPS for both the quarter and year-to-date periods. Gross margins compressed, and operating income fell sharply. Cash flow from operations decreased substantially, and a key segment (Feminine Care) is at risk of impairment. While international markets showed some organic growth and share repurchases increased, the overall financial performance indicates a challenging period with deteriorating profitability and cash generation.

Positives

• International markets showed organic net sales growth of 2.2% in the third quarter and 2.3% for the nine months, driven by price and volume gains in Wet Shave and Sun & Skin Care.
• Grooming products (part of Sun and Skin Care) increased 6.1% in the third quarter, led by Cremo.
• The Wet Shave segment's organic profit increased 2.3% in the third quarter and 5.4% for the nine months, due to higher gross margins and lower SG&A, partly offset by higher marketing expenses.
• Adjusted SG&A as a percentage of net sales was flat in the third quarter, driven by lower incentive compensation and favorable currency impacts.
• Net cash used for financing activities decreased significantly to $10.9 million for the nine months, compared to $139.3 million in the prior year, partly due to net borrowings on the revolving credit facility.
• The company repurchased 2.8 million shares for $90.2 million during the first nine months of fiscal 2025, an increase from $40.2 million in the prior year.
• Maintained a quarterly cash dividend of $0.15 per common share.

Negatives

• Overall net sales declined for both the three and nine months ended June 30, 2025.
• North America organic sales declined significantly (8.0% in the third quarter, 5.4% for nine months) due to volume declines and increased promotional levels across all segments.
• Net earnings and diluted EPS decreased substantially for both the three and nine months.
• Gross margin decreased by 150 basis points in the third quarter, impacted by core inflation, volume absorption, negative foreign currency, increased promotional levels, and unfavorable mix.
• Operating income decreased significantly due to lower sales and higher restructuring charges.
• Sun and Skin Care segment profit decreased 28.3% in the third quarter and 20.4% for the nine months, driven by lower gross margin and higher marketing and SG&A expenses.
• Feminine Care segment net sales decreased 10.5% in the third quarter and 10.5% for the nine months, with segment profit down 31.8% and 52.2% respectively, primarily due to lower gross profit.
• Cash flow from operating activities for the nine months decreased significantly from $157.3 million to $44.3 million, largely due to changes in net working capital and lower earnings.
• Increased capital expenditures to $49.4 million for the nine months, up from $30.6 million.
• Increased borrowing on the U.S. Revolving Credit Facility to $130.0 million from $34.0 million.
• The effective tax rate increased for the nine months ended June 30, 2025, reflecting less favorable discrete items.

Risks

• The fair value of the Feminine Care reporting unit exceeded its carrying value by less than 10% as of June 30, 2025, making it sensitive to future fluctuations in discount rates or declines in forecasted sales and margins, which could lead to impairment.
• Exposure to foreign currency risk, where a weakening of currencies relative to the U.S. dollar can unfavorably impact reported earnings.
• Interest rate risk on variable rate debt, with a one-percent increase in applicable interest rates potentially increasing annual interest expense by approximately $1.5 million on current variable-rate debt.
• General business risks and uncertainties detailed in the 2024 Annual Report, which have not materially changed.

Future Outlook

The company expects to incur approximately $44 million in pre-tax restructuring and related charges in fiscal 2025 as it continues to strengthen its operating model, simplify the organization, and improve manufacturing and supply chain efficiency, including the consolidation of Mexico operations expected to be completed by the second quarter of fiscal 2026. The recently enacted One Big Beautiful Bill Act (OBBBA) in the U.S. includes significant tax law changes, with certain provisions effective for the company beginning fiscal 2026, and the impact is currently being assessed. The company believes its cash on hand, cash flows from operations, and borrowing capacity will be sufficient to meet financial requirements for at least the next 12 months.

Management Comments

• "We analyze net sales and segment profit on an organic basis to better measure the comparability of results between periods."
• "Given certain significant events, we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance."
• "We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed."
• "We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material."
• "We believe our cash on hand, cash flows from operations and borrowing capacity under the U.S. Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, R&D activities, capital expenditures, and other financing requirements for at least the next 12 months."

Industry Context

The company's performance reflects broader industry challenges, particularly in North America, where volume declines and increased promotional activity impacted sales across Wet Shave, Sun Care, and Feminine Care segments. The Sun Care segment was specifically affected by weather-related volume declines and heightened competition. In contrast, international markets demonstrated resilience with organic growth driven by pricing, and the Grooming category, particularly Cremo, showed strong performance, indicating shifting consumer preferences or competitive dynamics within the personal care sector.

Comparison to Industry Standards

• No specific comparable companies, projects, or results were mentioned in the filing to provide a direct assessment against global benchmarks.

Legal Proceedings

• The company is subject to legal proceedings in various jurisdictions arising from ordinary course of business operations.
• Management believes that liability from pending legal proceedings, asserted claims, and known potential claims is not reasonably likely to be material to its financial position, results of operations, or cash flows, considering established accruals.

Stakeholder Impact

• Shareholders: Decreased net earnings and EPS could negatively impact shareholder value. Increased share repurchases could be seen as a positive for some, but the overall financial decline is concerning. Dividends are maintained.
• Employees: Restructuring actions, including the operating model redesign and Mexico facilities consolidation, will involve severance and related costs, indicating potential workforce reductions or reassignments.
• Customers: Increased promotional levels suggest efforts to retain or attract customers, potentially impacting brand perception or pricing power. Volume declines indicate reduced customer demand in some segments.
• Creditors: Increased borrowings on the U.S. Revolving Credit Facility indicate higher leverage, though the company remains in compliance with debt covenants.

Next Steps

• Continue to assess the impact of the One Big Beautiful Bill Act (OBBBA) tax law changes, effective fiscal 2026.
• Complete the consolidation of Mexico facilities by the second quarter of fiscal 2026.
• Continue to evaluate the fair value of goodwill and intangible assets through the fourth quarter of fiscal 2025 for potential impairment, especially for the Feminine Care reporting unit.
• Future share repurchases may be made based on market conditions, liquidity, and other factors.
• Quarterly cash dividend of $0.15 per common share payable on October 8, 2025, to shareholders of record on September 4, 2025.

Key Dates

Recommendation

The company's latest quarterly report reveals significant declines across key financial metrics, including net sales, net earnings, and diluted EPS, for both the quarter and the nine-month period. Gross margins have compressed, and operating income has fallen sharply. Cash flow from operating activities has seen a substantial decrease, indicating deteriorating operational efficiency and cash generation. Furthermore, the Feminine Care segment's fair value is precariously close to its carrying value, signaling a potential future impairment risk. While international markets show some organic growth and the company increased share repurchases, the widespread declines in North America across core segments, coupled with increased restructuring charges and higher debt utilization, paint a concerning picture. These trends suggest fundamental challenges in market demand and profitability, warranting a cautious to negative outlook for investors.

Keywords

Edgewell, Personal Care, Wet Shave, Sun Care, Skin Care, Feminine Care, Schick, Wilkinson Sword, Edge, Skintimate, Billie, Banana Boat, Hawaiian Tropic, Jack Black, Bulldog, Cremo, Wet Ones, Playtex, Stayfree, Carefree, o.b., SEC Filing, 10-Q, Quarterly Report, Financial Results, Earnings, Revenue, Profit, Restructuring, Impairment, Debt, Share Repurchase, Dividends